ROGER GADDY: Open Payments
NPI 1669495917 · WINNSBORO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 29 payments from 18 companies in 2025. Trend: 2023 $638 · 2024 $688 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $105 |
| Xeris Pharmaceuticals, Inc. | 1 | $88 |
| Amgen Inc. | 3 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| PFIZER INC. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Novo Nordisk Inc | 2 | $32 |
| Recor Medical Inc | 1 | $29 |
| ABBVIE INC. | 2 | $29 |
Products named: Dexcom G6 Transmitter, KEVEYIS, OTEZLA, GEMTESA, XIFAXAN, PREVNAR 20, CAPLYTA, Paradise Ultrasound Renal Denervation System.
Industry payments across SC — which companies pay providers there.
